ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,003,862 | -43.1% | 6,984,319 | -41.3% | 0.83% | -34.4% |
Q2 2023 | $43,911,941 | +11.5% | 11,900,255 | 0.0% | 1.27% | +9.3% |
Q1 2023 | $39,389,844 | -14.7% | 11,900,255 | 0.0% | 1.16% | -10.3% |
Q4 2022 | $46,172,989 | +73.8% | 11,900,255 | +8.8% | 1.30% | +68.2% |
Q3 2022 | $26,568,000 | +16.5% | 10,933,387 | -5.1% | 0.77% | +8.0% |
Q2 2022 | $22,812,000 | +4.5% | 11,521,102 | -3.5% | 0.71% | +63.4% |
Q1 2022 | $21,838,000 | -35.1% | 11,933,387 | -50.0% | 0.44% | +68.1% |
Q4 2021 | $33,652,000 | +124.6% | 23,866,774 | +80.0% | 0.26% | +19.3% |
Q3 2021 | $14,986,000 | -71.8% | 13,262,375 | -60.0% | 0.22% | -36.8% |
Q2 2021 | $53,072,000 | +81.8% | 33,169,604 | +100.0% | 0.34% | -6.5% |
Q1 2021 | $29,189,000 | -9.7% | 16,584,802 | 0.0% | 0.37% | +6.3% |
Q4 2020 | $32,340,000 | -18.4% | 16,584,802 | 0.0% | 0.35% | -40.1% |
Q3 2020 | $39,638,000 | -18.4% | 16,584,802 | 0.0% | 0.58% | -26.4% |
Q2 2020 | $48,593,000 | +1.7% | 16,584,802 | 0.0% | 0.79% | -36.7% |
Q1 2020 | $47,764,000 | +3.6% | 16,584,802 | +44.0% | 1.24% | +36.0% |
Q4 2019 | $46,084,000 | -10.1% | 11,521,102 | 0.0% | 0.92% | -33.7% |
Q3 2019 | $51,268,000 | +15.0% | 11,521,102 | 0.0% | 1.38% | +35.0% |
Q2 2019 | $44,586,000 | +80.4% | 11,521,102 | +76.7% | 1.02% | +46.8% |
Q1 2019 | $24,715,000 | +70.0% | 6,521,102 | 0.0% | 0.70% | +26.0% |
Q4 2018 | $14,542,000 | -64.1% | 6,521,102 | 0.0% | 0.55% | -48.9% |
Q3 2018 | $40,496,000 | +37.7% | 6,521,102 | 0.0% | 1.08% | +40.5% |
Q2 2018 | $29,410,000 | +67.3% | 6,521,102 | +70.7% | 0.77% | +56.7% |
Q1 2018 | $17,577,000 | +43.3% | 3,821,102 | 0.0% | 0.49% | +20.9% |
Q4 2017 | $12,266,000 | +176.1% | 3,821,102 | +164.9% | 0.41% | +378.8% |
Q3 2017 | $4,442,000 | +60.4% | 1,442,204 | +100.0% | 0.08% | -38.8% |
Q2 2017 | $2,769,000 | -21.3% | 721,102 | 0.0% | 0.14% | -30.5% |
Q1 2017 | $3,519,000 | -4.7% | 721,102 | 0.0% | 0.20% | -24.0% |
Q4 2016 | $3,692,000 | -30.7% | 721,102 | -1.9% | 0.26% | -23.5% |
Q3 2016 | $5,327,000 | – | 734,793 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |